REVIEW ON PHARMACOGNOSTIC SCHEME ON ENTIRE PLANT OF CLITORIA TERNATEA (BLUE BUTTERFLY PEA)

Ashvini Kambale*, Amol V. Pore, Gopika D. Dongare, Sanjay K. Bais

Herbal treatments are gaining widespread acceptance globally as natural options for managing various rapid-onset and long-term disorders. Convolvulus pluricaulis—commonly known as C. microphyllus or C. prostratus is a well-known ethnomedicinal plant valued for its broad spectrum of healing benefits. Research indicates that this species and its derivatives possess numerous neurotherapeutic actions, including enhancing memory retention, calming anxiety, uplifting mood, combating stress, inducing relaxation, reducing discomfort, scavenging free radicals, moderating inflammation, suppressing convulsions, and offering neuroprotective effects against Alzheimer’s disease. These secondary metabolites affect neural signaling, cognitive capacity, mental health, addiction patterns, and serotonin balance by modulating neural proteins, synaptic activity, intracellular cascades, and serotonergic pathways. Traditionally, it is employed to manage disorders like excessive blood glucose, raised arterial pressure, fluid accumulation, vision impairments, and digestive irregularities. Butterfly pea petals are increasingly acknowledged as safe and beneficial components in health promoting food formulations. Multiple significant chemical constituents such as aparajitin, clitorin, triterpenoid compounds, anthocyanin pigments, steroid-linked glycosides, and flavonol derivatives have been reported in Clitoria ternatea. This botanical species exhibits a wide array of pharmacological functions, including enhancing learning and memory, reducing seizure activity, providing anti-anxiety and anti-depressant effects, lowering stress response, protecting liver tissues, reducing lipid levels, easing pain, and inhibiting platelet clumping.